180 Life Sciences Stock Plunges Amid Ethereum's Decline
PorAinvest
viernes, 15 de agosto de 2025, 1:21 am ET1 min de lectura
ATNF--
The stock's recent surge can be attributed to the company's Ethereum treasury strategy, which involves accumulating 82,186 ETH valued at approximately $349 million. This strategy aims to become a benchmark for on-chain treasury management among public companies, with a differentiated yield generation program facilitated through a partnership with Electric Capital. The company believes this reserve of ETH will unlock cash flow for shareholders through its on-chain yield generation program.
Ethereum's price has been volatile, with a 3.38% increase to $4,431 over a 24-hour period, marking a 24% increase from the previous week. The company's treasury strategy is part of its broader evolution from a biotechnology company to a software-enabled gaming and entertainment enterprise.
Despite the recent gains, the stock's after-hours decline reflects the broader market's reaction to Ethereum's price drop. The company's stock has seen a year-to-date increase of 83.52% and a 91.95% rise over the past 12 months. The recent announcement has led to heavy trading, with approximately 33 million shares changing hands today compared to a three-month average of about 4.78 million units.
References:
[1] https://finance.yahoo.com/news/180-life-sciences-ethzilla-holds-120000891.html
[2] https://www.ainvest.com/news/ethereum-surges-4-400-180-life-sciences-stock-rises-132-rebranding-ethzilla-corporation-2508/
ETH--
180 Life Sciences Corp. shares slid 1.45% in after-hours trading, coinciding with the decline of Ethereum. The biotechnology company's stock has surged 116% in a week and 755% in a month, aligning with ETH's rise. The firm holds 82,186 ETH, valued at over $381 million, and plans to rebrand as ETHZilla Corporation. Billionaire venture capitalist Peter Thiel holds a 7.5% stake in the firm.
180 Life Sciences Corp. (ATNF) shares slid 1.45% in after-hours trading, coinciding with the decline of Ethereum. The biotechnology company's stock has surged 116% in a week and 755% in a month, aligning with ETH's rise. The firm holds 82,186 ETH, valued at over $381 million, and plans to rebrand as ETHZilla Corporation. Billionaire venture capitalist Peter Thiel holds a 7.5% stake in the firm.The stock's recent surge can be attributed to the company's Ethereum treasury strategy, which involves accumulating 82,186 ETH valued at approximately $349 million. This strategy aims to become a benchmark for on-chain treasury management among public companies, with a differentiated yield generation program facilitated through a partnership with Electric Capital. The company believes this reserve of ETH will unlock cash flow for shareholders through its on-chain yield generation program.
Ethereum's price has been volatile, with a 3.38% increase to $4,431 over a 24-hour period, marking a 24% increase from the previous week. The company's treasury strategy is part of its broader evolution from a biotechnology company to a software-enabled gaming and entertainment enterprise.
Despite the recent gains, the stock's after-hours decline reflects the broader market's reaction to Ethereum's price drop. The company's stock has seen a year-to-date increase of 83.52% and a 91.95% rise over the past 12 months. The recent announcement has led to heavy trading, with approximately 33 million shares changing hands today compared to a three-month average of about 4.78 million units.
References:
[1] https://finance.yahoo.com/news/180-life-sciences-ethzilla-holds-120000891.html
[2] https://www.ainvest.com/news/ethereum-surges-4-400-180-life-sciences-stock-rises-132-rebranding-ethzilla-corporation-2508/

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios